Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
National Institutes of Health Clinical Center (CC)
Hoffmann-La Roche
Children's Oncology Group
University of Nebraska
University Health Network, Toronto
RECORDATI GROUP
University of California, San Francisco
Merck Sharp & Dohme LLC